$1.14 -0.05 (-3.94%)

Barinthus Biotherapeutics plc American Depositary Shares (BRNS)

Company News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)

GlobeNewswire Inc. • Brodsky & Smith • October 16, 2025

Law firm Brodsky & Smith is investigating potential breaches of fiduciary duties by boards of several companies during merger and acquisition processes, questioning whether shareholders are receiving fair value.

ETNB DAY VRNT

Infection-Focused Barinthus Bio's VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives

Benzinga • Vandana Singh • April 19, 2024

On Friday, Barinthus Biotherapeutics plc (NASDAQ:BRNS), formerly Vaccitech plc, released topline final data from the APOLLO trial (HPV001) Phase 1b/2 dose-ranging trial of VTP-200 in women with low-grade cervical lesions associated with persistent High-risk human papillomavirus (hrHPV) infection. “While we didn’t observe a significant impr...

Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research • Zacks Equity Research • March 19, 2024

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of -54.05% and 2.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

SYBX